Fraudulent promotion of the CIMAvax EGF vaccine

2017-09-15T11:44:04+00:00

  Fraudulent promotion of the CIMAvax-EGF vaccine 30/07/2015 Dated 13 July 2015, the Center of Molecular Immunology (CIM) had knowledge of the existence of a WEB site located on a server in Seattle, United States (www.cimavaxcuba.com), which provides fraudulent promotion of the CIMAvax- EGF vaccine, a drug developed and patented by the CIM. About [...]

Fraudulent promotion of the CIMAvax EGF vaccine 2017-09-15T11:44:04+00:00

CIMAVAX-EGF for non-small cell lung cancer vaccine

2017-11-06T13:51:24+00:00

CIMAVAX-EGF for non-small cell lung cancer vaccine CIMAVAX-EGF is the first worldwide registered therapeutic vaccine for non-small lung cancer developed in Cuba by the Center for Molecular Immunology in conjunction with the Center for Genetic Engineering and Biotechnology. In 2008 it was approved by the Cuban regulatory authority for the use in adults with [...]

CIMAVAX-EGF for non-small cell lung cancer vaccine 2017-11-06T13:51:24+00:00

Patients in 34 countries recover eyesight thanks to Cuba and Venezuela

2017-09-15T11:44:05+00:00

All over Cuba these days there are celebrations of the tenth anniversary of "Operation Miracle." The U.S. public knows almost nothing about this internationalized project involving the restoration of vision for enormous numbers of people. Set in motion on July 8, 2004, Operation Miracle took shape within the context of the Bolivarian Alliance for [...]

Patients in 34 countries recover eyesight thanks to Cuba and Venezuela 2017-09-15T11:44:05+00:00